News & Media
Archives
-
Nov 28 2018DUBLIN, Ohio, November 28, 2018 — Cordis, a Cardinal Health company (NYSE: CAH), today announced that the U.S. Food and Drug Administration (FDA) has approved its INCRAFT® AAA Stent Graft...
Nov 28 2018Operating Room Automated Supply Chain Solution Simplifies Operations and Improves Patient ExperienceCardinal Health inventory management solutions (also known as WaveMark™) has introduced a supply chain automation solution designed for the unique challenges hospitals face in operating rooms...
-
Nov 27 2018Cardinal Health introduces approach to address sustainable cost controlAt the 2018 American Society of Health System Pharmacists (ASHP) Midyear Clinical Meeting, Cardinal Health will highlight a comprehensive approach that addresses the top concern of hospital and...
-
Nov 08 2018- Revenue increased 8 percent to $35.2 billionCardinal Health (NYSE: CAH) today reported first quarter fiscal year 2019 revenues of $35.2 billion, an increase of 8 percent. The company also reported growth in GAAP operating earnings of 211...
-
Nov 02 2018Cordis, a Cardinal Health company, today announced the U.S. launch of MYNX CONTROL™ Vascular Closure Device (VCD). MYNX CONTROL™ VCD integrates active...
Get news alerts by email
Complete the form below to receive e-mail notifications of our news releases. You will receive an email which you must reply to in order to confirm your subscription. You may unsubscribe from our list at anytime.